Microdosing Collective Launches Around Safe and Regulated Access to Sub-Perceptible Doses of Psychedelics

Microdosing Collective Launches Around Safe and Regulated Access to Sub-Perceptible Doses of Psychedelics
CANNANNEW REPORT

There is a rapidly growing movement to create safe access to psychedelic medicines. As the psychedelic renaissance grows, consumer interest in microdosing psychedelics for wellness is building. The Microdosing Collective (“Microdosing Collective” or “the Collective”) is a new initiative supporting education around regulatory policy to permit legal microdosing for optimal wellbeing.   The Microdosing Collective is an non-profit educational organization committed to a world where sub-perceptible microdosing of psychedelics (beginning with psilocybin) is legal, accessible and safe. One potential path forward is to regulate microdoses of psychedelics as over-the-counter wellness supplements under the purview of the Food and Drug Administration (FDA) or a state-based system. “Over the past few years, there have been incredible strides made to provide psychedelic substances within a legal and regulated framework,” says Paul Austin, Microdosing Collective Co-Founder and microdosing expert. “Unfortunately, none of these initiatives have created policy specific to the adult use of microdosing psychedelics. We seek to change that.” The United States government is permitting clinical research studies on the benefits of psychedelics after decades of fighting the war on drugs and stifling investigations. There are currently dozens of research studies investigating the immense therapeutic potential of psychedelics for PTSD, addiction, and treatment-resistant depression. Most FDA-approved research studies focus on the clinical outcomes of using consciousness-altering doses of psychedelics during guided sessions. Additionally, state-regulated models only allow access to quantities of psychedelics that dramatically shift consciousness. Regulatory frameworks for the use of psychedelics only allow access to mind-altering doses of psychedelics under the supervision of a licensed professional. Regulatory pathways to accessing sub-perceptible doses of psychedelics do not exist. “The Collective estimates at least 600,000 people in the U.S. actively microdose psychedelic medicines. The problem we are addressing is that none of these products are legal or guaranteed to be safe,” says Joshua Kappel, a…

Excerpt only …
READ MORE BELOW
Source : Microdosing Collective Launches Around Safe and Regulated Access to Sub-Perceptible Doses of Psychedelics

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.